Hepatitis C virus inhibitors
US9340520B2 · kind B2 · utility
4Cited by
8References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 4, 2013 |
| Grant date | May 17, 2016 |
| Priority date | — |
| Expiry date | Sep 4, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D405/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.